Articles related to HEART FAILURE (HF)

Age-adjusted mortality data reveals remarkable therapeutic success in acute ischemic events while highlighting emerging challenges in chronic cardiovascular conditions requiring enhanced primary care management strategies.

Four-month mitoquinone supplementation reversed early indicators of cardiac metabolic stress in Type 2 diabetes patients, improving heart energy efficiency by 15% compared to standard treatment alone.

First randomized evidence supporting feasibility of maintaining cardiac stability with carvedilol alone after systematic withdrawal of other heart failure medications in selected patients.

FRESH-UP found no benefit in health status, hospitalizations, or mortality when restricting fluids to 1,500 mL daily in stable heart failure patients, while significantly increasing thirst distress.

Community-based centers with limited resources should identify an on-site clinician to serve as their ‘shock champion’ as well as a center providing advanced heart failure therapies to partner with on complex CS cases.

In this comprehensive analysis of 2,853 TTS patients, beta-blocker therapy demonstrated a significant 29% reduction in mortality risk during follow-up, particularly within the first year after discharge.